Agile adaptation in mRNA-LNP manufacturing: A CDMO's response to rapidly evolving needs
Leveraging mRNA and LNP expertise, Samsung Biologics offers clients flexible scale-up from lab through commercial manufacturing—to precisely tailor to each project and uphold scientific excellence.
- Cost-efficient IVT with fed-batch optimization
- Reduced dsRNA & improved capping using modified T7 polymerase
- Fit-for-purpose LNP formulation and novel lipid evaluation
- End-to-end support from PD to GMP manufacturing
Leveraging mRNA and LNP expertise, Samsung Biologics offers clients flexible scale-up from lab through commercial manufacturing—to precisely tailor to each project and uphold scientific excellence.
- Cost-efficient IVT with fed-batch optimization
- Reduced dsRNA & improved capping using modified T7 polymerase
- Fit-for-purpose LNP formulation and novel lipid evaluation
- End-to-end support from PD to GMP manufacturing
Related Content